Biosynex (ALBIO) — Financial Flexibility Index
Biosynex (ALBIO) has a Financial Flexibility Index of -0.05x as of June 2025. Free cash flow of €-5.49 Million (operating CF €-7.07 Million minus capex €1.58 Million) represents 0% of total liabilities (€105.13 Million). Also explore net asset growth rate of Biosynex to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biosynex Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Biosynex across 12 annual periods. Check ALBIO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Biosynex (2008–2024)
Year-by-year free cash flow to debt coverage for Biosynex. For the full company profile including market capitalisation, see market cap of Biosynex.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.05x | €-5.28 Million | €-10.12 Million | €114.19 Million | ▼ -118.2% |
| 2023 | 0.25x | €29.89 Million | €-9.65 Million | €117.41 Million | ▼ -32.3% |
| 2022 | 0.38x | €35.03 Million | €4.95 Million | €93.21 Million | ▼ -70.5% |
| 2021 | 1.27x | €128.85 Million | €109.83 Million | €101.14 Million | ▲ +86.9% |
| 2020 | 0.68x | €40.75 Million | €31.64 Million | €59.78 Million | ▲ +13.2% |
| 2019 | 0.60x | €10.22 Million | €1.10 Million | €16.97 Million | ▼ -35.9% |
| 2018 | 0.94x | €9.58 Million | €467.12K | €10.20 Million | ▲ +13.6% |
| 2017 | 0.83x | €9.60 Million | €484.82K | €11.60 Million | ▲ +2458.3% |
| 2016 | 0.03x | €489.91K | €489.91K | €15.15 Million | ▼ -52.2% |
| 2015 | 0.07x | €461.66K | €461.66K | €6.82 Million | ▼ -45.2% |
| 2009 | 0.12x | €119.33K | €72.40K | €965.95K | ▲ +156.0% |
| 2008 | -0.22x | €-161.13K | €-184.44K | €731.01K | — |